Embecta Corp
(STU:JX7)
€
19
0 (0%)
Market Cap: 1.14 Bil
Enterprise Value: 2.42 Bil
PE Ratio: 15.02
PB Ratio: 0
GF Score: 52/100 Embecta Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023 / 06:55PM GMT
Release Date Price:
€15.6
(+1.96%)
Kallum L Titchmarsh
Morgan Stanley, Research Division - Research Associate
Perfect. Thank you, everyone, for coming. Very pleased to have the team from Embecta. Here today, we've got Dev, CEO; Jake, CFO; and Pravesh from IR here as well.
Just before I get started, I've got to read you some disclosures briefly. Any disclosures regarding this conference, please see www.morganstanley.com/researchdisclosures or please contact your Morgan Stanley sales representative.
Questions & Answers
Kallum L Titchmarsh
Morgan Stanley, Research Division - Research Associate
So Dev, I [wanted] to start today just touching on the pretty solid fiscal year Q3 performance recently. And maybe you provide some high-level takes from that and the key drivers there?
Devdatt Kurdikar
Embecta Corp. - President, CEO & Director
Yes, happy to do that. First of all, thank you for having us, Kallum. Strong quarter. Really pleased with
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot